Abstract
Epilepsy represents the most common maternal neurological disorder requiring continuous treatment during pregnancy. Maintaining optimum seizure control is an important objective in pregnancy, and the majority of women with epilepsy will need to continue antiepileptic drugs (AEDs). AEDs are frequently used to treat several other conditions, such as headaches and mood disorders. They have been associated with an increased risk of congenital malformations, minor anomalies, congenital syndrome and development disorders. This risk seems to be higher among women using polypharmacy and valproic acid. Neural tube defects are associated with valproic acid and carbamazepine exposure. New AEDs seem to have a less teratogenic effect, but human experience is still limited. The purpose of this review is to provide an update on AED exposure in pregnancy, focusing on pharmacokinetics and transplacental transport.
Keywords: Antiepileptic drugs, epilepsy, pharmacokinetics, placenta, placental transfer, pregnancy, teratology, mood disorders, congenital malformations, development disorders, polypharmacy and valproic acid, Neural tube defects, transplacental transport
Current Pharmaceutical Biotechnology
Title: Antiepileptic Drugs During Pregnancy: Pharmacokinetics and Transplacental Transfer
Volume: 12 Issue: 5
Author(s): Marco De Santis, Carmen De Luca, Ilenia Mappa, Elena Cesari, Tomasella Quattrocchi, Terryann Spagnuolo, Daniela Visconti and Alessandro Caruso
Affiliation:
Keywords: Antiepileptic drugs, epilepsy, pharmacokinetics, placenta, placental transfer, pregnancy, teratology, mood disorders, congenital malformations, development disorders, polypharmacy and valproic acid, Neural tube defects, transplacental transport
Abstract: Epilepsy represents the most common maternal neurological disorder requiring continuous treatment during pregnancy. Maintaining optimum seizure control is an important objective in pregnancy, and the majority of women with epilepsy will need to continue antiepileptic drugs (AEDs). AEDs are frequently used to treat several other conditions, such as headaches and mood disorders. They have been associated with an increased risk of congenital malformations, minor anomalies, congenital syndrome and development disorders. This risk seems to be higher among women using polypharmacy and valproic acid. Neural tube defects are associated with valproic acid and carbamazepine exposure. New AEDs seem to have a less teratogenic effect, but human experience is still limited. The purpose of this review is to provide an update on AED exposure in pregnancy, focusing on pharmacokinetics and transplacental transport.
Export Options
About this article
Cite this article as:
De Santis Marco, De Luca Carmen, Mappa Ilenia, Cesari Elena, Quattrocchi Tomasella, Spagnuolo Terryann, Visconti Daniela and Caruso Alessandro, Antiepileptic Drugs During Pregnancy: Pharmacokinetics and Transplacental Transfer, Current Pharmaceutical Biotechnology 2011; 12 (5) . https://dx.doi.org/10.2174/138920111795470958
DOI https://dx.doi.org/10.2174/138920111795470958 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Multiple Roles of Vitamin D in Human Health. A Mini-Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Editorial [Hot Topic: New Mechanisms of Neuronal Injury and Neuroprotection (Guest Editor: Weihai Ying)]
Current Drug Targets Comparative Study of LC/MS and EMIT in Therapeutic Monitoring of Carbamazepine and its Clinical Applications
Current Pharmaceutical Analysis Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update
Current Pharmaceutical Design Molecular Genetics and Biomarkers of Polyglutamine Diseases
Current Molecular Medicine Classical and New Renin-Angiotensin Signalling in Atherosclerosis
Current Signal Transduction Therapy Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival
Current Drug Targets - CNS & Neurological Disorders Editorial (Thematic Issue: Neurology and Genetics: How Molecular Biology is Changing the Neurological Thoughts?)
Current Molecular Medicine Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
Current Neuropharmacology Assessing Structure, Function and Druggability of Major Inhibitory Neurotransmitter γ-Aminobutyrate Symporter Subtypes
Current Medicinal Chemistry MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
Current Alzheimer Research The Clinics and Etiology of Preeclampsia
Current Women`s Health Reviews Editorial [Hot topic:VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)]
Current Pharmaceutical Design Animal Peptides Targeting Voltage-Activated Sodium Channels
Current Pharmaceutical Design Topiramate: Its Pharmacological Properties and Therapeutic Efficacy in Epilepsy
Mini-Reviews in Medicinal Chemistry Fad Diets: Dietary Dilemmas, Predicaments, and Recommendations for its Use
Current Nutrition & Food Science